154 related articles for article (PubMed ID: 28108512)
1. Constitutive NOTCH3 Signaling Promotes the Growth of Basal Breast Cancers.
Choy L; Hagenbeek TJ; Solon M; French D; Finkle D; Shelton A; Venook R; Brauer MJ; Siebel CW
Cancer Res; 2017 Mar; 77(6):1439-1452. PubMed ID: 28108512
[TBL] [Abstract][Full Text] [Related]
2. NOTCH3 expression is linked to breast cancer seeding and distant metastasis.
Leontovich AA; Jalalirad M; Salisbury JL; Mills L; Haddox C; Schroeder M; Tuma A; Guicciardi ME; Zammataro L; Gambino MW; Amato A; Di Leonardo A; McCubrey J; Lange CA; Liu M; Haddad T; Goetz M; Boughey J; Sarkaria J; Wang L; Ingle JN; Galanis E; D'Assoro AB
Breast Cancer Res; 2018 Sep; 20(1):105. PubMed ID: 30180881
[TBL] [Abstract][Full Text] [Related]
3. FGFR signaling promotes the growth of triple-negative and basal-like breast cancer cell lines both in vitro and in vivo.
Sharpe R; Pearson A; Herrera-Abreu MT; Johnson D; Mackay A; Welti JC; Natrajan R; Reynolds AR; Reis-Filho JS; Ashworth A; Turner NC
Clin Cancer Res; 2011 Aug; 17(16):5275-86. PubMed ID: 21712446
[TBL] [Abstract][Full Text] [Related]
4. GRB7 dependent proliferation of basal-like, HER-2 positive human breast cancer cell lines is mediated in part by HER-1 signaling.
Luoh SW; Wagoner W; Wang X; Hu Z; Lai X; Chin K; Sears R; Ramsey E
Mol Carcinog; 2019 May; 58(5):699-707. PubMed ID: 30604896
[TBL] [Abstract][Full Text] [Related]
5. NOTCH3 signaling pathway plays crucial roles in the proliferation of ErbB2-negative human breast cancer cells.
Yamaguchi N; Oyama T; Ito E; Satoh H; Azuma S; Hayashi M; Shimizu K; Honma R; Yanagisawa Y; Nishikawa A; Kawamura M; Imai J; Ohwada S; Tatsuta K; Inoue J; Semba K; Watanabe S
Cancer Res; 2008 Mar; 68(6):1881-8. PubMed ID: 18339869
[TBL] [Abstract][Full Text] [Related]
6. Characterization of activating mutations of NOTCH3 in T-cell acute lymphoblastic leukemia and anti-leukemic activity of NOTCH3 inhibitory antibodies.
Bernasconi-Elias P; Hu T; Jenkins D; Firestone B; Gans S; Kurth E; Capodieci P; Deplazes-Lauber J; Petropoulos K; Thiel P; Ponsel D; Hee Choi S; LeMotte P; London A; Goetcshkes M; Nolin E; Jones MD; Slocum K; Kluk MJ; Weinstock DM; Christodoulou A; Weinberg O; Jaehrling J; Ettenberg SA; Buckler A; Blacklow SC; Aster JC; Fryer CJ
Oncogene; 2016 Nov; 35(47):6077-6086. PubMed ID: 27157619
[TBL] [Abstract][Full Text] [Related]
7. Cartilage Oligomeric Matrix Protein initiates cancer stem cells through activation of Jagged1-Notch3 signaling.
Papadakos KS; Bartoschek M; Rodriguez C; Gialeli C; Jin SB; Lendahl U; Pietras K; Blom AM
Matrix Biol; 2019 Aug; 81():107-121. PubMed ID: 30502484
[TBL] [Abstract][Full Text] [Related]
8. IL6 blockade potentiates the anti-tumor effects of γ-secretase inhibitors in Notch3-expressing breast cancer.
Wang D; Xu J; Liu B; He X; Zhou L; Hu X; Qiao F; Zhang A; Xu X; Zhang H; Wicha MS; Zhang L; Shao ZM; Liu S
Cell Death Differ; 2018 Feb; 25(2):330-339. PubMed ID: 29027990
[TBL] [Abstract][Full Text] [Related]
9. Notch3 inhibits cell proliferation and tumorigenesis and predicts better prognosis in breast cancer through transactivating PTEN.
Zhang YQ; Liang YK; Wu Y; Chen M; Chen WL; Li RH; Zeng YZ; Huang WH; Wu JD; Zeng D; Gao WL; Chen CF; Lin HY; Yang RQ; Zhu JW; Liu WL; Bai JW; Wei M; Wei XL; Zhang GJ
Cell Death Dis; 2021 May; 12(6):502. PubMed ID: 34006834
[TBL] [Abstract][Full Text] [Related]
10. Lymphatic endothelium stimulates melanoma metastasis and invasion via MMP14-dependent Notch3 and β1-integrin activation.
Pekkonen P; Alve S; Balistreri G; Gramolelli S; Tatti-Bugaeva O; Paatero I; Niiranen O; Tuohinto K; Perälä N; Taiwo A; Zinovkina N; Repo P; Icay K; Ivaska J; Saharinen P; Hautaniemi S; Lehti K; Ojala PM
Elife; 2018 May; 7():. PubMed ID: 29712618
[TBL] [Abstract][Full Text] [Related]
11. Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers.
Konishi J; Kawaguchi KS; Vo H; Haruki N; Gonzalez A; Carbone DP; Dang TP
Cancer Res; 2007 Sep; 67(17):8051-7. PubMed ID: 17804716
[TBL] [Abstract][Full Text] [Related]
12. Tyrosine phosphorylation profiling reveals the signaling network characteristics of Basal breast cancer cells.
Hochgräfe F; Zhang L; O'Toole SA; Browne BC; Pinese M; Porta Cubas A; Lehrbach GM; Croucher DR; Rickwood D; Boulghourjian A; Shearer R; Nair R; Swarbrick A; Faratian D; Mullen P; Harrison DJ; Biankin AV; Sutherland RL; Raftery MJ; Daly RJ
Cancer Res; 2010 Nov; 70(22):9391-401. PubMed ID: 20861192
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase 6 controls Notch3 trafficking and degradation in T-cell acute lymphoblastic leukemia cells.
Pinazza M; Ghisi M; Minuzzo S; Agnusdei V; Fossati G; Ciminale V; Pezzè L; Ciribilli Y; Pilotto G; Venturoli C; Amadori A; Indraccolo S
Oncogene; 2018 Jul; 37(28):3839-3851. PubMed ID: 29643474
[TBL] [Abstract][Full Text] [Related]
14. Notch3 signalling promotes tumour growth in colorectal cancer.
Serafin V; Persano L; Moserle L; Esposito G; Ghisi M; Curtarello M; Bonanno L; Masiero M; Ribatti D; Stürzl M; Naschberger E; Croner RS; Jubb AM; Harris AL; Koeppen H; Amadori A; Indraccolo S
J Pathol; 2011 Aug; 224(4):448-60. PubMed ID: 21598247
[TBL] [Abstract][Full Text] [Related]
15. Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer.
Gastaldi S; Sassi F; Accornero P; Torti D; Galimi F; Migliardi G; Molyneux G; Perera T; Comoglio PM; Boccaccio C; Smalley MJ; Bertotti A; Trusolino L
Oncogene; 2013 Mar; 32(11):1428-40. PubMed ID: 22562252
[TBL] [Abstract][Full Text] [Related]
16. Insights into the regulation of tumor dormancy by angiogenesis in experimental tumors.
Indraccolo S
Adv Exp Med Biol; 2013; 734():37-52. PubMed ID: 23143974
[TBL] [Abstract][Full Text] [Related]
17. Notch3-mediated regulation of MKP-1 levels promotes survival of T acute lymphoblastic leukemia cells.
Masiero M; Minuzzo S; Pusceddu I; Moserle L; Persano L; Agnusdei V; Tosello V; Basso G; Amadori A; Indraccolo S
Leukemia; 2011 Apr; 25(4):588-98. PubMed ID: 21263446
[TBL] [Abstract][Full Text] [Related]
18. NOTCH3-targeted antibody drug conjugates regress tumors by inducing apoptosis in receptor cells and through transendocytosis into ligand cells.
Geles KG; Gao Y; Giannakou A; Sridharan L; Yamin TT; Zhang J; Karim R; Bard J; Piche-Nicholas N; Charati M; Maderna A; Lucas J; Golas J; Guffroy M; Pirie-Shepherd S; Roy M; Qian J; Franks T; Zhong W; O'Donnell CJ; Tchistiakova L; Gerber HP; Sapra P
Cell Rep Med; 2021 May; 2(5):100279. PubMed ID: 34095881
[TBL] [Abstract][Full Text] [Related]
19. NOTCH3 signaling regulates MUSASHI-1 expression in metastatic colorectal cancer cells.
Pastò A; Serafin V; Pilotto G; Lago C; Bellio C; Trusolino L; Bertotti A; Hoey T; Plateroti M; Esposito G; Pinazza M; Agostini M; Nitti D; Amadori A; Indraccolo S
Cancer Res; 2014 Apr; 74(7):2106-18. PubMed ID: 24525742
[TBL] [Abstract][Full Text] [Related]
20. Targeting Notch signaling with a Notch2/Notch3 antagonist (tarextumab) inhibits tumor growth and decreases tumor-initiating cell frequency.
Yen WC; Fischer MM; Axelrod F; Bond C; Cain J; Cancilla B; Henner WR; Meisner R; Sato A; Shah J; Tang T; Wallace B; Wang M; Zhang C; Kapoun AM; Lewicki J; Gurney A; Hoey T
Clin Cancer Res; 2015 May; 21(9):2084-95. PubMed ID: 25934888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
